Sökning: onr:"swepub:oai:gup.ub.gu.se/321308" > Outcomes of Cerebra...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 06676naa a2201297 4500 | |
001 | oai:gup.ub.gu.se/321308 | |
003 | SwePub | |
008 | 240802s2022 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/3213082 URI |
024 | 7 | a https://doi.org/10.1161/strokeaha.122.0395752 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a van de Munckhof, A.4 aut |
245 | 1 0 | a Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase |
264 | 1 | b Ovid Technologies (Wolters Kluwer Health),c 2022 |
520 | a Background: Cerebral venous thrombosis (CVT) due to vaccine-induced immune thrombotic thrombocytopenia (VITT) is a severe condition, with high in-hospital mortality rates. Here, we report clinical outcomes of patients with CVT-VITT after SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccination who survived initial hospitalization. Methods: We used data from an international registry of patients who developed CVT within 28 days of SARS-CoV-2 vaccination, collected until February 10, 2022. VITT diagnosis was classified based on the Pavord criteria. Outcomes were mortality, functional independence (modified Rankin Scale score 0-2), VITT relapse, new thrombosis, and bleeding events (all after discharge from initial hospitalization). Results: Of 107 CVT-VITT cases, 43 (40%) died during initial hospitalization. Of the remaining 64 patients, follow-up data were available for 60 (94%) patients (37 definite VITT, 9 probable VITT, and 14 possible VITT). Median age was 40 years and 45/60 (75%) patients were women. Median follow-up time was 150 days (interquartile range, 94-194). Two patients died during follow-up (3% [95% CI, 1%-11%). Functional independence was achieved by 53/60 (88% [95% CI, 78%-94%]) patients. No new venous or arterial thrombotic events were reported. One patient developed a major bleeding during follow-up (fatal intracerebral bleed). Conclusions: In contrast to the high mortality of CVT-VITT in the acute phase, mortality among patients who survived the initial hospitalization was low, new thrombotic events did not occur, and bleeding events were rare. Approximately 9 out of 10 CVT-VITT patients who survived the acute phase were functionally independent at follow-up. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Neurovetenskaper0 (SwePub)301052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Neurosciences0 (SwePub)301052 hsv//eng |
653 | a hospitalization | |
653 | a intracranial thrombosis | |
653 | a mortality | |
653 | a thrombocytopenia | |
653 | a vaccination | |
653 | a venous thrombosis | |
653 | a sinus thrombosis | |
653 | a risk | |
653 | a Neurosciences & Neurology | |
653 | a Cardiovascular System & Cardiology | |
700 | 1 | a Lindgren, Erik,d 1993u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap,Institute of Neuroscience and Physiology, Department of Clinical Neuroscience4 aut0 (Swepub:gu)xliere |
700 | 1 | a Kleinig, T. J.4 aut |
700 | 1 | a Field, T. S.4 aut |
700 | 1 | a Cordonnier, C.4 aut |
700 | 1 | a Krzywicka, K.4 aut |
700 | 1 | a Poli, S.4 aut |
700 | 1 | a van Kammen, M. S.4 aut |
700 | 1 | a Borhani-Haghighi, A.4 aut |
700 | 1 | a Lemmens, R.4 aut |
700 | 1 | a Scutelnic, A.4 aut |
700 | 1 | a Ciccone, A.4 aut |
700 | 1 | a Gattringer, T.4 aut |
700 | 1 | a Wittstock, M.4 aut |
700 | 1 | a Dizonno, V.4 aut |
700 | 1 | a Devroye, A.4 aut |
700 | 1 | a Elkady, A.4 aut |
700 | 1 | a Gunther, A.4 aut |
700 | 1 | a Cervera, A.4 aut |
700 | 1 | a Mengel, A.4 aut |
700 | 1 | a Chew, B. L. A.4 aut |
700 | 1 | a Buck, B.4 aut |
700 | 1 | a Zanferrari, C.4 aut |
700 | 1 | a Garcia-Esperon, C.4 aut |
700 | 1 | a Jacobi, C.4 aut |
700 | 1 | a Soriano, C.4 aut |
700 | 1 | a Michalski, D.4 aut |
700 | 1 | a Zamani, Z.4 aut |
700 | 1 | a Blacquiere, D.4 aut |
700 | 1 | a Johansson, Elias,d 19844 aut |
700 | 1 | a Cuadrado-Godia, E.4 aut |
700 | 1 | a Vuillier, F.4 aut |
700 | 1 | a Bode, F. J.4 aut |
700 | 1 | a Caparros, F.4 aut |
700 | 1 | a Maier, F.4 aut |
700 | 1 | a Tsivgoulis, G.4 aut |
700 | 1 | a Katzberg, H. D.4 aut |
700 | 1 | a Duan, J. G.4 aut |
700 | 1 | a Burrow, J.4 aut |
700 | 1 | a Pelz, J.4 aut |
700 | 1 | a Mbroh, J.4 aut |
700 | 1 | a Oen, J.4 aut |
700 | 1 | a Schouten, J.4 aut |
700 | 1 | a Zimmermann, J.4 aut |
700 | 1 | a Ng, K.4 aut |
700 | 1 | a Garambois, K.4 aut |
700 | 1 | a Petruzzellis, M.4 aut |
700 | 1 | a Dias, M. C.4 aut |
700 | 1 | a Ghiasian, M.4 aut |
700 | 1 | a Romoli, M.4 aut |
700 | 1 | a Miranda, M.4 aut |
700 | 1 | a Wronski, M.4 aut |
700 | 1 | a Skjelland, M.4 aut |
700 | 1 | a Almasi-Dooghaee, M.4 aut |
700 | 1 | a Cuisenier, P.4 aut |
700 | 1 | a Murphy, S.4 aut |
700 | 1 | a Timsit, S.4 aut |
700 | 1 | a Coutts, S. B.4 aut |
700 | 1 | a Schonenberger, S.4 aut |
700 | 1 | a Nagel, S.4 aut |
700 | 1 | a Hiltunen, S.4 aut |
700 | 1 | a Chatterton, S.4 aut |
700 | 1 | a Cox, T.4 aut |
700 | 1 | a Bartsch, T.4 aut |
700 | 1 | a Shaygannejad, V.4 aut |
700 | 1 | a Mirzaasgari, Z.4 aut |
700 | 1 | a Middeldorp, S.4 aut |
700 | 1 | a Levi, M. M.4 aut |
700 | 1 | a Hovinga, J. A. K.4 aut |
700 | 1 | a Jood, Katarina,d 1966u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap,Institute of Neuroscience and Physiology, Department of Clinical Neuroscience4 aut0 (Swepub:gu)xjooka |
700 | 1 | a Tatlisumak, Turgutu Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap,Institute of Neuroscience and Physiology, Department of Clinical Neuroscience4 aut0 (Swepub:gu)xtatlt |
700 | 1 | a Putaala, J.4 aut |
700 | 1 | a Heldner, M. R.4 aut |
700 | 1 | a Arnold, M.4 aut |
700 | 1 | a de Sousa, D. A.4 aut |
700 | 1 | a Ferro, J. M.4 aut |
700 | 1 | a Coutinho, J. M.4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap4 org |
773 | 0 | t Stroked : Ovid Technologies (Wolters Kluwer Health)g 53:10, s. 3206-3210q 53:10<3206-3210x 0039-2499x 1524-4628 |
856 | 4 8 | u https://gup.ub.gu.se/publication/321308 |
856 | 4 8 | u https://doi.org/10.1161/strokeaha.122.039575 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.